GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Hemispherx Biopharma, Inc. (HEB) [hlAlert]

Hemispherx Biopharma, Inc. (Hemispherx) is a biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic
disorders. The Company?s products include Ampligen and Alferon N and Injection. Ampligen includes application as a treatment for Chronic Fatigue Syndrome (CFS) and as a vaccine enhancer(adjuvant) for both therapeutic and preventative vaccine development. Alferon N is an indicator for refractory or recurring genital warts. Alferon LDO (Low Dose Oral) is an application under early stage development targeting influenza and viral diseases. Ampligen is an experimental drug undergoing clinical development for the treatment of CFS.
.
( Total: 3 Current Stock Recommendations )
Hemispherx Biopharma, Inc.   (3)
Hold 33% Buy 67%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
CELSION CORP   (6)
Buy 100%
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Buy HEB
down 22.72 %

Rating:
Buy HEB
down 62.22 %

Rating:
Hold HEB
Hemispherx Biopharma, Inc. (HEB) rated Hold
Monday,  Dec 10, 2007  1:25 PM ET

Your Recent Stocks
SymbolLastChange
HEB 0.17 up  6.25 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy